Publicacións en colaboración con investigadores/as de Hospital Universitario de Canarias (23)

2024

  1. Analysis of Random Lasing in Human Blood

    Biosensors, Vol. 14, Núm. 9

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2018

  1. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease

    Experimental Neurology, Vol. 299, pp. 137-147

2014

  1. Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

    Frontiers in Neuroanatomy, Vol. 8, Núm. AUG

2012

  1. Neonatal apneic seizure of occipital lobe origin: Continuous video-EEG recording

    Pediatrics, Vol. 129, Núm. 6

2007

  1. Cloning and functional expression of a new epithelial sodium channel δ subunit isoform differentially expressed in neurons of the human and monkey telencephalon

    Journal of Neurochemistry, Vol. 102, Núm. 4, pp. 1304-1315

2006

  1. Glycine release in the substantia nigra: Interaction with glutamate and GABA

    Neuropharmacology, Vol. 50, Núm. 5, pp. 548-557

2005

  1. Glial regulation of nonsynaptic extracellular glutamate in the substania nigra

    GLIA, Vol. 49, Núm. 1, pp. 134-142

  2. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells

    European Journal of Neuroscience, Vol. 21, Núm. 7, pp. 1815-1827

2004

  1. Effect of intracerebroventricular injection of lipopolysaccharide on the tuberoinfundibular dopaminergic system of the rat

    Neuroscience, Vol. 127, Núm. 1, pp. 251-259

  2. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons

    Journal of Comparative Neurology, Vol. 479, Núm. 2, pp. 198-215

  3. Extracellular Taurine in the Substantia Nigra: Taurine-Glutamate Interaction

    Journal of Neuroscience Research, Vol. 76, Núm. 4, pp. 528-538

  4. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat

    Movement Disorders, Vol. 19, Núm. 9, pp. 1029-1042

2003

  1. Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: Different action on GABA cell subpopulations

    Movement Disorders, Vol. 18, Núm. 3, pp. 254-266

2002

  1. Response of GABAergic cells in the deep mesencephalic nucleus to dopaminergic cell degeneration: An electrophysiological and in situ hybridization study

    Neuroscience, Vol. 113, Núm. 2, pp. 311-321

2001

  1. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons

    European Journal of Neuroscience, Vol. 13, Núm. 1, pp. 57-67

  2. Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: An animal model of Parkinson's disease

    Behavioural Brain Research, Vol. 122, Núm. 1, pp. 79-92

  3. The deep mesencephalic nucleus as an output center of basal ganglia: Morphological and electrophysiological similarities with the substantia nigra

    Journal of Comparative Neurology, Vol. 438, Núm. 1, pp. 12-31

1996

  1. Relative and combined effects of propylthiouracil, ethanol and protein deficiency on muscle

    Alcohol and Alcoholism, Vol. 31, Núm. 2, pp. 157-165

1992

  1. Pathogenesis of alcoholic myopathy: roles of ethanol and malnutrition

    Drug and Alcohol Dependence, Vol. 30, Núm. 2, pp. 101-110